Free Trial
→ Iran's New Leader Just Said Something That Should Terrify Every American (From American Alternative) (Ad)tc pixel Free GBNHF Stock Alerts

This company has been marked as potentially delisted and may not be actively trading.

Greenbrook TMS (GBNHF) Competitors

Compare

GBNHF vs. DHAC, NIVF, BACK, BTTX, and UPHL

Should you be buying Greenbrook TMS stock or one of its competitors? The main competitors of Greenbrook TMS include Digital Health Acquisition (DHAC), NewGenIvf Group (NIVF), IMAC (BACK), Better Therapeutics (BTTX), and UpHealth (UPHL). These companies are all part of the "healthcare" industry.

How does Greenbrook TMS compare to Digital Health Acquisition?

Greenbrook TMS (NASDAQ:GBNHF) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

Digital Health Acquisition has a net margin of 0.00% compared to Greenbrook TMS's net margin of -70.28%.

Company Net Margins Return on Equity Return on Assets
Greenbrook TMS-70.28% N/A -98.87%
Digital Health Acquisition N/A N/A N/A

1.0% of Digital Health Acquisition shares are held by institutional investors. 21.7% of Greenbrook TMS shares are held by company insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Digital Health Acquisition has lower revenue, but higher earnings than Greenbrook TMS.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greenbrook TMS$73.79M0.01-$48.91M-$1.23N/A
Digital Health AcquisitionN/AN/AN/AN/AN/A

In the previous week, Greenbrook TMS's average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company Overall Sentiment
Greenbrook TMS Neutral
Digital Health Acquisition Neutral

Greenbrook TMS has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Comparatively, Digital Health Acquisition has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500.

Summary

Greenbrook TMS and Digital Health Acquisition tied by winning 3 of the 6 factors compared between the two stocks.

How does Greenbrook TMS compare to NewGenIvf Group?

Greenbrook TMS (NASDAQ:GBNHF) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

NewGenIvf Group has a net margin of 0.00% compared to Greenbrook TMS's net margin of -70.28%.

Company Net Margins Return on Equity Return on Assets
Greenbrook TMS-70.28% N/A -98.87%
NewGenIvf Group N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Greenbrook TMS
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
NewGenIvf Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

66.2% of NewGenIvf Group shares are held by institutional investors. 21.7% of Greenbrook TMS shares are held by insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

NewGenIvf Group has lower revenue, but higher earnings than Greenbrook TMS.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Greenbrook TMS$73.79M0.01-$48.91M-$1.23N/A
NewGenIvf Group$4.73M0.08$9.88MN/AN/A

In the previous week, NewGenIvf Group had 2 more articles in the media than Greenbrook TMS. MarketBeat recorded 2 mentions for NewGenIvf Group and 0 mentions for Greenbrook TMS. Greenbrook TMS's average media sentiment score of 0.00 beat NewGenIvf Group's score of -0.23 indicating that Greenbrook TMS is being referred to more favorably in the media.

Company Overall Sentiment
Greenbrook TMS Neutral
NewGenIvf Group Neutral

Greenbrook TMS has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.04, indicating that its stock price is 96% less volatile than the S&P 500.

Summary

NewGenIvf Group beats Greenbrook TMS on 8 of the 11 factors compared between the two stocks.

How does Greenbrook TMS compare to IMAC?

IMAC (NASDAQ:BACK) and Greenbrook TMS (NASDAQ:GBNHF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

IMAC has higher earnings, but lower revenue than Greenbrook TMS. IMAC is trading at a lower price-to-earnings ratio than Greenbrook TMS, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$72.05K2.05-$9.42M-$3.12N/A
Greenbrook TMS$73.79M0.01-$48.91M-$1.23N/A

IMAC has a beta of 1.7, meaning that its share price is 70% more volatile than the S&P 500. Comparatively, Greenbrook TMS has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500.

In the previous week, IMAC's average media sentiment score of 0.00 equaled Greenbrook TMS'saverage media sentiment score.

Company Overall Sentiment
IMAC Neutral
Greenbrook TMS Neutral

5.8% of IMAC shares are owned by institutional investors. 12.3% of IMAC shares are owned by company insiders. Comparatively, 21.7% of Greenbrook TMS shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

IMAC has a net margin of 0.00% compared to Greenbrook TMS's net margin of -70.28%.

Company Net Margins Return on Equity Return on Assets
IMACN/A N/A -325.44%
Greenbrook TMS -70.28%N/A -98.87%

Summary

IMAC and Greenbrook TMS tied by winning 5 of the 10 factors compared between the two stocks.

How does Greenbrook TMS compare to Better Therapeutics?

Better Therapeutics (NASDAQ:BTTX) and Greenbrook TMS (NASDAQ:GBNHF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

Better Therapeutics has higher earnings, but lower revenue than Greenbrook TMS. Greenbrook TMS is trading at a lower price-to-earnings ratio than Better Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A
Greenbrook TMS$73.79M0.01-$48.91M-$1.23N/A

Better Therapeutics has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Comparatively, Greenbrook TMS has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500.

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled Greenbrook TMS'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
Greenbrook TMS Neutral

34.0% of Better Therapeutics shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by company insiders. Comparatively, 21.7% of Greenbrook TMS shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Better Therapeutics has a net margin of 0.00% compared to Greenbrook TMS's net margin of -70.28%.

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
Greenbrook TMS -70.28%N/A -98.87%

Summary

Better Therapeutics beats Greenbrook TMS on 7 of the 9 factors compared between the two stocks.

How does Greenbrook TMS compare to UpHealth?

UpHealth (NYSE:UPHL) and Greenbrook TMS (NASDAQ:GBNHF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment.

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Comparatively, 21.7% of Greenbrook TMS shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

UpHealth has a net margin of 0.00% compared to Greenbrook TMS's net margin of -70.28%.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
Greenbrook TMS -70.28%N/A -98.87%

Greenbrook TMS has lower revenue, but higher earnings than UpHealth. Greenbrook TMS is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.47N/A
Greenbrook TMS$73.79M0.01-$48.91M-$1.23N/A

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Greenbrook TMS'saverage media sentiment score.

Company Overall Sentiment
UpHealth Neutral
Greenbrook TMS Neutral

UpHealth has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Greenbrook TMS has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500.

Summary

UpHealth beats Greenbrook TMS on 7 of the 9 factors compared between the two stocks.

Get Greenbrook TMS News Delivered to You Automatically

Sign up to receive the latest news and ratings for GBNHF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GBNHF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GBNHF vs. The Competition

Export
MetricGreenbrook TMShealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ Exchange
Market Cap$408K$79.31M$6.25B$11.77B
Dividend YieldN/AN/A2.74%5.26%
P/E Ratio-0.010.7429.2527.07
Price / Sales0.010.14504.1475.42
Price / CashN/A4.1943.3053.90
Price / Book0.000.159.676.69
Net Income-$48.91M$25.15M$3.55B$332.64M

Greenbrook TMS Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GBNHF
Greenbrook TMS
N/A$0.01
flat		N/AN/A$408K$73.79MN/A430
DHAC
Digital Health Acquisition
N/A$0.21
+0.2%		N/AN/A$766KN/AN/A2,021
NIVF
NewGenIvf Group
1.3653 of 5 stars		$1.96
flat		N/AN/A$490K$4.73MN/AN/A
BACK
IMAC
N/A$0.05
flat		N/AN/A$195K$72.05KN/A180
BTTX
Better Therapeutics
N/A$0.00
flat		N/AN/A$4KN/AN/A40

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:GBNHF) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel